NKGen Biotech Inc.NKGen Biotech Inc.NKGen Biotech Inc.

NKGen Biotech Inc.

No trades
See on Supercharts

NKGN fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NKGN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company